BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9004911)

  • 21. Investigations of avidin and biotin for imaging applications.
    Hnatowich DJ; Virzi F; Rusckowski M
    J Nucl Med; 1987 Aug; 28(8):1294-302. PubMed ID: 3612292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab Radioimmunotherapy (RIT) with Accelerated Blood Clearance Using the Avidin Chase.
    Yudistiro R; Hanaoka H; Katsumata N; Yamaguchi A; Tsushima Y
    Mol Pharm; 2018 Jun; 15(6):2165-2173. PubMed ID: 29733658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of experimental infections with 99mTc-labeled monoclonal antibodies against TNF-alpha and interleukin-8.
    Welling M; Feitsma HI; Calame W; Pauwels EK
    Nucl Med Biol; 1997 Oct; 24(7):649-55. PubMed ID: 9352536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody.
    Pimm MV; Fells HF; Perkins AC; Baldwin RW
    Nucl Med Commun; 1988 Nov; 9(11):931-41. PubMed ID: 3251178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technetium-99m-labeled monoclonal antibodies for immunoscintigraphy. Simplified preparation and evaluation.
    Thakur ML; DeFulvio JD
    J Immunol Methods; 1991 Mar; 137(2):217-24. PubMed ID: 2013698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid blood clearance of biotinylated IgG after infusion of avidin.
    Sinitsyn VV; Mamontova AG; Checkneva YY; Shnyra AA; Domogatsky SP
    J Nucl Med; 1989 Jan; 30(1):66-9. PubMed ID: 2911044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased renal accumulation of biotinylated chimeric monoclonal antibody-neocarzinostatin conjugate after administration of avidin.
    Otsuji E; Yamaguchi T; Yamamoto K; Matsumura H; Tsuruta H; Yata Y; Nishi H; Okamoto K; Kitamura K; Takahashi T
    Jpn J Cancer Res; 1997 Feb; 88(2):205-12. PubMed ID: 9119750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patients.
    Lazzeri E; Manca M; Molea N; Marchetti S; Consoli V; Bodei L; Bianchi R; Chinol M; Paganelli G; Mariani G
    Eur J Nucl Med; 1999 Jun; 26(6):606-14. PubMed ID: 10369946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of human melanoma xenografts in nude mice with a radiolabeled monoclonal antibody.
    Ghose T; Ferrone S; Imai K; Norvell ST; Luner SJ; Martin RH; Blair AH
    J Natl Cancer Inst; 1982 Oct; 69(4):823-6. PubMed ID: 6956760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of neocarzinostatin conjugated to biotinylated chimeric monoclonal antibody Fab fragments after administration of avidin.
    Otsuji E; Yamaguchi T; Matsumura H; Yamamoto K; Tsuruta H; Yata Y; Nishi H; Okamoto K; Kitamura K; Takahashi T
    Br J Cancer; 1996 Aug; 74(4):597-602. PubMed ID: 8761376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
    Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
    Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological evaluation of avidin-based tumor pretargeting with DOTA-Triazole-Biotin constructed via versatile Cu(I) catalyzed click chemistry.
    Uppal JK; Varshney R; Hazari PP; Chuttani K; Kaushik NK; Mishra AK
    J Drug Target; 2011 Jul; 19(6):418-26. PubMed ID: 20678008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.
    Wang Z; Garkavij M; Ohlsson T; Strand SE; Sjögren HO; Tennvall J
    Cancer Biother Radiopharm; 2003 Jun; 18(3):365-75. PubMed ID: 12954123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes.
    Oyen WJ; Boerman OC; Storm G; van Bloois L; Koenders EB; Claessens RA; Perenboom RM; Crommelin DJ; van der Meer JW; Corstens FH
    J Nucl Med; 1996 Aug; 37(8):1392-7. PubMed ID: 8708782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling.
    Wang Z; Mårtensson L; Nilsson R; Bendahl PO; Lindgren L; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7171s-7177s. PubMed ID: 16203818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin.
    Rosebrough SF
    Nucl Med Biol; 1993 Jul; 20(5):663-8. PubMed ID: 8358353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avidin-biotin system: a small library of cysteine biotinylated derivatives designed for the [99mTc(N)(PNP)]2+ metal fragment.
    Bolzati C; Caporale A; Agostini S; Carta D; Cavazza-Ceccato M; Refosco F; Tisato F; Schievano E; Bandoli G
    Nucl Med Biol; 2007 Jul; 34(5):511-22. PubMed ID: 17591551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
    J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody.
    Schwarz SW; Connett JM; Anderson CJ; Rocque PA; Philpott GW; Guo LW; Welch MJ
    Nucl Med Biol; 1994 May; 21(4):619-26. PubMed ID: 9234319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.
    Subbiah K; Hamlin DK; Pagel JM; Wilbur DS; Meyer DL; Axworthy DB; Mallett RW; Theodore LJ; Stayton PS; Press OW
    J Nucl Med; 2003 Mar; 44(3):437-45. PubMed ID: 12621012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.